Tuesday Jul 8
Customer Interaction Solutions
Analysts Review Releases Notes on Alere, AMRI, Anika Therapeutics,...
On July 4, Analysts Review released its analysts' notes regarding Alere, Albany Molecular Research, Anika Therapeutics, Nektar Therapeutics and Sangamo Biosciences.
Investor's Business Daily
Albany Molecular's Oso Buy Seen Boosting Earnings
In a report issued Monday morning, Sterne Agee analyst Greg Bolan said he is "officially incorporating our estimates for accretion" into Albany's earnings for this year and next year.
AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing
AMRI today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners, LLC. The transaction is consistent with AMRI's strategy to be the preeminent supplier of custom and complex drug product development and manufacturing services to the pharmaceutical industry.
Albany Molecular Research Reaches New 12-Month High at $21.14
Albany Molecular Research hit a new 52-week high on Tuesday , American Banking News.com reports.
Albany Molecular Research, Inc. (AMRI) Announces Early Termination Of ...
The early termination of the HSR waiting period satisfies one of the conditions to the proposed acquisition.
Ciminelli seeks added tax breaks for AMRI at Conventus
The addition of Albany Molecular Research Inc. as an anchor tenant in the Conventus project is prompting the developers to seek a separate incentive package for the company's local expansion plans.